Skip to content
Sanctiometer
Beta This record is aggregated from OFSI's public list — verify against the issuing authority before acting.
No official photo — sanctions bodies publish none.

OFSI sanctions listing

GSK ADVANCE

high risk OFSI · Sudan Organization
List-based indicator — from authority, programme severity & linked parties.

GSK ADVANCE is an organisation designated on the HM Treasury — Office of Financial Sanctions Implementation (OFSI) (OFSI) sanctions list under the Sudan programme, listed on 12/07/2023. This page summarises the public designation — known aliases, identifying particulars, the stated reason for listing and linked parties — alongside an independent, transparent risk indicator.

Reason for listing

(UK Sanctions List Ref):SUD0010. (UK Statement of Reasons):GSK is an involved person under the Sudan (Sanctions) (EU Exit) Regulations 2020. GSK is associated with RSF, an ‘involved person’ fighting for power in Sudan. GSK is one of RSF’s ‘front companies’ and is controlled by the head of RSF’s brother. RSF is an armed group and GSK supports it with funds and goods and equipment to fight. GSK provides funds for activity which threatens the peace, stability and security of Sudan, as an enabler of RSF’s participation in the conflict in Sudan. GSK is an involved person responsible for activity which threatens the peace, stability and security of Sudan. (Phone number):+249930020401 (Website):https://web.archive.org/web/20191031092520/http:/gsk-it.com/

Statement of reasons as published by UK OFSI. This is the issuing authority's wording, reproduced for reference.

Designation record

List / authorityUK OFSI (OFSI) — Sudan
Entity typeOrganization
Programmes / regimeSudan
Date listed12/07/2023
Source record IDofsi:16008
Last updated (our copy)2026-06-04

Identity & particulars

Nationality / countrySudan
Address(es)Ahmed Khair Street, Khartoum · 11111 Sudan

Deep-research dossier

Not yet deep-researched

The instant review above is drawn from the public lists. A deep-research dossier goes much further — an analyst-grade OSINT report: associate & co-investment network screening, structural / ownership opacity, a dated risk trajectory, an 8-factor scoring model, and numbered, source-linked evidence. See the format in the design system.

Standard depth · 3 credits

Clarifications & right of reply

Are you GSK ADVANCE, or an authorised representative?

You — or your counsel or agent — can file a clarification and supporting documents against this record. Filings are reviewed and verified before anything is published; submissions are never posted automatically.

File a clarification or document

Source & provenance

Issuing authorityHM Treasury — Office of Financial Sanctions Implementation (OFSI)
Source identifierofsi:16008
Aggregated bySanctiometer (independent) — verify against the issuing authority's official list before acting.

← Back to search